You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

checkpoint inhibitors

Showing 1 - 25 of 5,188
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Checkpoint Inhibitors in Solid Tumors:Retrospective Real-world

Recruiting
  • Immunotherapy
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Feb 8, 2023

    Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

    Recruiting
    • Non Small Cell Lung Cancer
    • FAPI PET/CT
    • Brussels, Belgium
      Institut Jules Bordet
    Oct 24, 2023

    Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

    Completed
    • Immune Checkpoint Inhibitor
    • Endocrine Toxicity
      • Nanjing, Jiangsu, China
        First Affiliated Hospital, Nanjing Medical University
      Jan 6, 2023

      Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Immune Checkpoint Inhibitors
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Oct 5, 2023

      Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Arterial Doppler for Flow Mediated Reserve measurement
      • Paris, France
        INstitut Mutualiste Montsouris
      Aug 29, 2023

      CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

      Completed
      • Paraneoplastic Syndromes
      • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Jul 11, 2023

      Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

      Recruiting
      • Immunotherapy
      • +5 more
      • blood retriewal
      • Amiens, Picardie, France
        CHU Amiens Picardie
      Apr 3, 2023

      Immune Checkpoint Inhibitor-related Cardiotoxicity

      Not yet recruiting
      • Immune Checkpoint Inhibitors, Cardiotoxicity
      • Cardiac magnetic resonance
      • (no location specified)
      Nov 10, 2023

      Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

      Completed
      • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
      • Wenzhou, Zhejiang, China
        The First Affiliated Hospital of Wenzhou Medical University
      Nov 6, 2023

      Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

      Not yet recruiting
      • Cervical Cancer
      • Cervical Carcinoma
      • Guangzhou, China
        Sun Yat-sen University Cancer Cetntre
      Apr 9, 2023

      Lung Cancer Trial in Wuhan (Pirfenidone)

      Recruiting
      • Lung Cancer
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Mar 24, 2023

      Troponin to Detect Major Cardiovasculaire Advserse Events on

      Recruiting
      • Cancer
      • +2 more
      • No intervention
      • Paris, France
        Institut Mutualiste Montsouris
      Aug 22, 2023

      Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

      Recruiting
      • Immune Checkpoint Inhibitor
      • +3 more
      • Blood sample
      • Amiens, France
        CHU Amiens
      Dec 8, 2022

      NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

      Not yet recruiting
      • NSCLC Associated With Leptomeningeal Metastases
      • Tislelizumab, pemetrexed
      • (no location specified)
      Nov 21, 2023

      Checkpoint Inhibitors in Triple Negative Breast

      Recruiting
      • Triple Negative Breast Cancer
      • Whole Genome Sequencing
      • +7 more
      • Barcelona, Spain
        Vall d'Hebron Institute of Oncology
      Jun 20, 2023

      SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

      Recruiting
      • SCLC,Extensive Stage
      • Thoracic radiotherapy
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Sep 14, 2022

      Solid Tumor Trial in Ann Arbor (Potato starch)

      Suspended
      • Solid Tumor
      • Potato starch
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Oct 10, 2022

      Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

      Active, not recruiting
      • Tumor Skin
      • +2 more
      • OBX-115
      • Orlando, Florida
      • +1 more
      Sep 28, 2023

      Myocarditis Trial (Abatacept 250 MG)

      Not yet recruiting
      • Myocarditis
      • Abatacept 250 MG
      • (no location specified)
      Jul 5, 2022

      Uterine Cervical Tumors, Cancer of Cervix, Cervical Cancer Trial (Cadonilimab, Nab paclitaxel)

      Not yet recruiting
      • Uterine Cervical Neoplasms
      • +5 more
      • (no location specified)
      Apr 9, 2023

      Myocarditis, Immune Checkpoint Inhibitors, Cardiotoxicity Trial in Adelaide (Immune Checkpoint Inhibitors)

      Recruiting
      • Myocarditis
      • +3 more
      • Immune Checkpoint Inhibitors
      • Adelaide, South Australia, Australia
        Flinders Medical Centre
      Apr 21, 2022

      Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

      Not yet recruiting
      • Breast Cancer
      • Contrast Enhanced Ultrasound
      • Hershey, Pennsylvania
        Penn State Health College of Medicine
      Jul 19, 2023

      Melanoma (Skin) Trial in Nice, Montpellier, Lille (Evaluation of cytokine production)

      Not yet recruiting
      • Melanoma (Skin)
      • Evaluation of cytokine production
      • Nice, Alpes-maritimes, France
      • +2 more
      Dec 5, 2022